
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BPR001
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : MEDIN Fund Management Company
Deal Size : Undisclosed
Deal Type : Financing
Biper Therapeutics Secures €1M to Advance First-in-Class Cancer Therapy into Trials
Details : The financing for BPR001 will support the development of gastrointestinal cancer treatments targeting GRP78 | BiP.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
December 02, 2025
Lead Product(s) : BPR001
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : MEDIN Fund Management Company
Deal Size : Undisclosed
Deal Type : Financing
